Biscayne Pharmaceuticals is Drug Discovery in United States that focus on refractory epilepsy business. Founded in 2012. They cover business area such as developer, drug, therapy, (GHRH, receptor, tissue growth, repair, patient, treatment, multiple type, difficult-to-treat tumor.
2012
( 12 years old in 2024 )
Refractory Epilepsy
-
4770 Biscayne Boulevard
Suite 660
Miami, FL 33137
United States
Private
developerdrugtherapy(GHRHreceptortissue growthrepairpatienttreatmentmultiple typedifficult-to-treat tumor
* We use standard office opening hours in near Biscayne Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Biscayne Pharmaceuticals is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Biscayne Pharmaceuticals business is focusing on Refractory Epilepsy.
Biscayne Pharmaceuticals headquarter office and corporate office address is located in 4770 Biscayne Boulevard Suite 660 Miami, FL 33137 United States.
Biscayne Pharmaceuticals was founded in United States.
In 2024, Biscayne Pharmaceuticals is currently focus on refractory epilepsy sector.
Above is snippet of Google Trends for "refractory epilepsy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Biscayne Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
